Increasing evidence suggests Alzheimer\u27s disease (AD) pathophysiology is influenced by primary and secondary bile acids, the end product of cholesterol metabolism. We analyze 2,114 post-mortem brain transcriptomes and identify genes in the alternative bile acid synthesis pathway to be expressed in the brain. A targeted metabolomic analysis of primary and secondary bile acids measured from post-mortem brain samples of 111 individuals supports these results. Our metabolic network analysis suggests that taurine transport, bile acid synthesis, and cholesterol metabolism differ in AD and cognitively normal individuals. We also identify putative transcription factors regulating metabolic genes and influencing altered metabolism in AD. Intrigui...
The metabolic basis of Alzheimer disease (AD) pathology and expression of AD symptoms is poorly unde...
Alzheimer’s disease (AD) is the most common cause of adult dementia. Yet the complete set of molecul...
BackgroundThere is growing evidence that Alzheimer disease (AD) is a pervasive metabolic disorder wi...
Increasing evidence suggests Alzheimer\u27s disease (AD) pathophysiology is influenced by primary an...
Increasing evidence suggests Alzheimer's disease (AD) pathophysiology is influenced by primary and s...
Increasing evidence suggests Alzheimer's disease (AD) pathophysiology is influenced by primary and s...
IntroductionIncreasing evidence suggests a role for the gut microbiome in central nervous system dis...
BACKGROUND: While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hyperchol...
IntroductionBile acids (BAs) are the end products of cholesterol metabolism produced by human and gu...
Background While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hyperchole...
INTRODUCTION:Bile acids (BAs) are the end products of cholesterol metabolism produced by human and g...
Introduction: Increasing evidence suggests a role for the gut microbiome in central nervous system d...
Certain endogenous bile acids have been proposed as potential therapies for ameliorating Alzheimer’s...
Background: Alterations in the brain-gut microbiome system are thought to play an important role in ...
The complex pathology of Alzheimer’s disease (AD) emphasises the need for comprehensive modelling of...
The metabolic basis of Alzheimer disease (AD) pathology and expression of AD symptoms is poorly unde...
Alzheimer’s disease (AD) is the most common cause of adult dementia. Yet the complete set of molecul...
BackgroundThere is growing evidence that Alzheimer disease (AD) is a pervasive metabolic disorder wi...
Increasing evidence suggests Alzheimer\u27s disease (AD) pathophysiology is influenced by primary an...
Increasing evidence suggests Alzheimer's disease (AD) pathophysiology is influenced by primary and s...
Increasing evidence suggests Alzheimer's disease (AD) pathophysiology is influenced by primary and s...
IntroductionIncreasing evidence suggests a role for the gut microbiome in central nervous system dis...
BACKGROUND: While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hyperchol...
IntroductionBile acids (BAs) are the end products of cholesterol metabolism produced by human and gu...
Background While Alzheimer disease (AD) and vascular dementia (VaD) may be accelerated by hyperchole...
INTRODUCTION:Bile acids (BAs) are the end products of cholesterol metabolism produced by human and g...
Introduction: Increasing evidence suggests a role for the gut microbiome in central nervous system d...
Certain endogenous bile acids have been proposed as potential therapies for ameliorating Alzheimer’s...
Background: Alterations in the brain-gut microbiome system are thought to play an important role in ...
The complex pathology of Alzheimer’s disease (AD) emphasises the need for comprehensive modelling of...
The metabolic basis of Alzheimer disease (AD) pathology and expression of AD symptoms is poorly unde...
Alzheimer’s disease (AD) is the most common cause of adult dementia. Yet the complete set of molecul...
BackgroundThere is growing evidence that Alzheimer disease (AD) is a pervasive metabolic disorder wi...